Appetite and Weight Change: A Symptom That Points Two Ways

What it is

Changes in appetite — and the weight changes that often follow — are among the most familiar symptoms of mood disorders and a great many medical conditions. What makes appetite distinctive among the symptoms in this series is that it is bidirectional: in depression it can swing in either direction, with some people losing their appetite and others eating more, and that direction is not random noise. It carries information about the kind of depression a person has and about the biology driving it. Appetite is therefore worth understanding not only as a source of distress but as a window into mechanism and subtype.

Two directions, two profiles

The classic, "melancholic" picture of depression involves decreased appetite and weight loss — food loses its appeal, meals are skipped, and the body's drive to eat is suppressed. The contrasting "atypical" picture involves increased appetite, carbohydrate craving, and weight gain, and it tends to travel with other atypical features such as heightened sleepiness and mood that still reacts to good events. Seasonal (winter) depression often shows this increased-appetite pattern.

These two directions appear to reflect genuinely different biology, not just different tastes. The increased-appetite pattern tracks closely with the immunometabolic profile that recurs throughout this library — higher inflammation, insulin resistance, metabolic disturbance — whereas decreased appetite aligns more with the high-arousal, stress-hormone-driven melancholic profile. The direction of an appetite change is, in effect, a clue pointing toward one mechanistic subtype or another.

The neurobiology of appetite

Appetite is governed by two interacting systems. The homeostatic system, centered in the hypothalamus, balances the body's energy needs by integrating hormonal signals — leptin from fat tissue and insulin signaling reduce hunger over the longer term, while ghrelin from the stomach drives it, alongside gut hormones that signal fullness after eating. The hedonic system is about eating for pleasure and reward, and it runs on the same dopamine-and-opioid reward circuitry that underlies anhedonia — which is why food's appeal can be blunted when reward processing is impaired, or heightened when food becomes a source of comfort.

In depression, these systems are pushed in different directions by different forces. Decreased appetite is associated with activation of the stress system: the hormone CRH, released in stress and prominent in melancholic states, suppresses appetite, as does heightened arousal. Increased appetite is associated with the immunometabolic route — inflammation, and disrupted leptin and insulin signaling, combined with reward-driven, "comfort" eating. Chronic stress specifically promotes intake of palatable food and the accumulation of abdominal fat through cortisol, linking appetite to the chronic stress and metabolic accounts. Serotonin contributes to the sense of fullness, which is part of why serotonergic medications affect appetite. And the newer GLP-1-based medications suppress appetite by acting on both hypothalamic and reward pathways — a mechanism of considerable current interest, with their psychiatric effects under active study and not yet settled.

Where it appears

Appetite change features in depression (both directions), bipolar disorder, anxiety, and PTSD, and in a wide range of medical conditions — endocrine disease, gastrointestinal illness, cancer, and infection among them. It is also one of the most clinically important medication effects in all of psychiatry: many psychiatric drugs change appetite and weight substantially. Some antipsychotics and the antidepressant mirtazapine, along with certain mood stabilizers, can drive considerable weight gain, while stimulants, bupropion, and topiramate tend to reduce appetite. Appetite disturbance is also, of course, central to the eating disorders, which are distinct conditions discussed below.

Why it matters

Appetite and weight change matter on several levels. As a diagnostic symptom, the direction of change helps identify subtype and points toward the underlying biology. As a medication effect, drug-induced weight gain is a leading cause of people stopping treatment and a major contributor to the cardiometabolic health problems that shorten the lives of people with serious mental illness — a consequence too often treated as cosmetic when it is medically serious. And appetite changes affect physical health, self-image, and daily function in their own right.

Treatment

The guiding principles are to treat the underlying condition, to interpret the appetite change as a clue, and to manage medication effects thoughtfully. Where weight gain is a concern, clinicians can favor agents with more neutral or favorable profiles (bupropion, for example, tends to be weight-neutral or reducing), and established medical strategies exist to counter antipsychotic-associated weight gain, alongside metabolic monitoring. Where appetite and weight are low — as in melancholic, geriatric, or medically ill patients — treating the depression and, where appropriate, using an appetite-stimulating agent such as mirtazapine can help, along with nutritional support. Reversible medical causes should always be sought.

A careful boundary applies here. This document concerns appetite as a symptom of mood and medical conditions; it is not guidance on diet, weight management, or eating behavior, and it deliberately offers no targets, plans, or numbers. When changes in eating become organized around control, restriction, bingeing, or compensatory behaviors, or become a source of significant distress, that points toward an eating disorder — a distinct set of conditions with their own drivers that warrant specialized assessment and care rather than being treated as a simple appetite symptom.

How it connects

Appetite ties several library threads together. Its bidirectionality is one of the clearest illustrations of the library's recurring theme that symptom direction reveals subtype, and the increased-appetite pattern is a defining feature of the immunometabolic subtype that links the inflammatory and metabolic accounts. Its hedonic component shares circuitry with anhedonia; its stress-driven side connects to the HPA-axis and chronic stress; and its sensitivity to medication links it to nearly every series in the pharmacology library.

Caveats

Appetite change is bidirectional, and the direction is diagnostically meaningful rather than incidental. Medication-induced weight change is a leading, under-addressed clinical problem with real health consequences. Eating disorders are distinct conditions that should not be conflated with appetite-as-symptom and require specialized care. And appetite and weight are freighted with cultural meaning and stigma, which can distort both how the symptom is experienced and how it is discussed — another reason to approach it with care and without judgment.

Bottom line

Appetite change is a symptom that points two ways, and the way it points matters: decreased appetite aligns with a stress-driven, melancholic biology, while increased appetite marks the inflammatory, immunometabolic subtype that recurs across this library. It is at once a diagnostic clue, a frequent and consequential medication effect, and a symptom that affects health and self-image directly. The thoughtful approach reads the direction of change for what it reveals, manages drug-induced weight effects as the serious medical issue they are, seeks reversible causes, and keeps a clear boundary between appetite as a symptom and the distinct, specialized territory of eating disorders.

Selected references

1. Simmons WK, et al. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2020.
2. Milaneschi Y, et al. Depression heterogeneity and its biological underpinnings: immunometabolic depression. Biol Psychiatry. 2020.
3. Morton GJ, et al. Central nervous system control of food intake and body weight. Nature. 2006.
4. Berthoud HR. Metabolic and hedonic drives in the neural control of appetite. Curr Opin Neurobiol. 2011.
5. Dallman MF, et al. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci USA. 2003.
6. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007.
7. Kroemer NB, Small DM. Fuel not fun: reinterpreting attenuated brain responses to reward in obesity. Physiol Behav. 2016.
8. Lasserre AM, et al. Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass. JAMA Psychiatry. 2014.
9. Allison DB, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999.
10. Correll CU, et al. Cardiometabolic risk in patients with severe mental illness. World Psychiatry. 2015.
11. Schwartz MW, et al. Central nervous system control of food intake. Nature. 2000.
12. Gibson-Smith D, et al. The relation between obesity and depressed mood: the role of eating behavior. Obes Rev. 2018.
13. Capuron L, et al. Chronic low-grade inflammation in metabolic and neuropsychiatric symptoms. Neuropsychopharmacology. 2017.
14. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake. Trends Cogn Sci. 2011.
15. Patsalos O, et al. Diet, obesity, and depression: a systematic review. J Pers Med. 2021.